Trial Information

Summary: Clinical trial to test a study dye in people undergoing Echocardiography

The purpose of this registry study is to provide information about the nature and the frequency of serious adverse events that occur up to 24 hours following the completion of DEFINITYŽ administration.

To qualify, you must:

  • Be at least 18 years old
  • Be a candidate for having an echocardiography

You will not qualify if you:

  • Are pregnant or breast-feeding
  • Have a known hypersensitivity to perflutren or any other echo contrast agent

Contact:

Samantha Buckley, Research Coordinator
Biomedical Research Alliance of New York
Mt Sinai Medical Center
Cardiovascular Institute
Box 1030
One Gustave L. Levy Place
New York, NY 10029
Telephone: 212-241-3078
Email:

Profile Page: Biomedical Research Alliance of New York, New York, NY

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:42:54 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA